Patent №
US 8,093,025
Granted
2012-01-10
Filed 2007
Owner
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11667034
The present invention relates to a combination of compounds for introducing nucleic acids and/or protein into animal cells, tissue, organs or organisms in vitro, extracorporal, or in vivo. This combination comprises preparations suitable for administration to an animal or human for medical purposes, comprising as one component a bacterial vector genetically manipulated to contain nucleic acid sequences comprising a transgene, and a second component for the subsequent transcription, possibly translation of the transgene by controlled induction of bacterial vector as it is present within the animal or human.
AI classification
Ownership
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
assignment · 196330115
Assignors
LOESSNER, HOLGER, ENDMANN, ANNE, LESCHNER, SARA, WEISS, SIEGFRIED
On an employer assignment, the assignors are typically the inventors.